Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

by | Jan 15, 2026 | Stock Market

Penumbra’s stock was up about 14% after the deal was announced Thursday morning.

Article Attribution | Read More at Article Source